![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-5.50 | -1.13% | 481.50 | 480.40 | 480.50 | 486.10 | 480.30 | 482.30 | 4,098,010 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3961 | 12.13 | 13.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
06/1/2020 11:12 | FWIW: Broker Forecast - Deutsche Bank issues a broker note on Aviva PLC 6 January 2020 | 08:50am StockMarketWire.com - Deutsche Bank today reaffirms its hold investment rating on Aviva PLC [LON:AV.] and raised its price target to 470p (from 450p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.c spud | spud | |
06/1/2020 09:33 | Oh, it's always easy to buy! | ![]() uppompeii | |
06/1/2020 09:06 | next top-up point coming - never thought it would be so easy to buy back into this. | ![]() eurofox | |
06/1/2020 08:31 | Deutsche Bank Hold 414.10 450.00 470.00 Reiterates | ![]() skinny | |
03/1/2020 21:23 | Good post spud. Av need to speed up changes. We seem to be slowing down. I'm hopeful that an active investor will get involved this year or maybe a takeover. Needs to be shaken up big time. Have a decent holding here. | ![]() oggyrocks | |
03/1/2020 12:19 | nice top-up this a.m. | ![]() eurofox | |
02/1/2020 11:25 | Experts predict insurance demerger trend to continue in 2020 by Duffie Osental 02 Jan 2020 Last year saw the country’s biggest insurer, Prudential Plc, spin-off M&G, its UK and European savings and investments business – and experts are predicting that the demerger trend may continue this year. The last few years have seen significant instances of insurers offloading businesses to allow them to focus on core operations. Some of the more noteworthy examples include Esure’s 2016 demerger from price comparison site GoCompare and Standard Life selling its insurance business to Phoenix Group in 2018. Now, analysts have told Financial Times that stiffer capital requirements may cause more demergers to happen in 2020 – with insurance giants Aviva, Saga, RSA, and Admiral likely to have plans to downsize this year. “The evidence for having a diverse [insurance] group is fairly scant,” Rob James, a fund manager at Merian Global Investors, told Financial Times. Aviva, for instance, has already started to downsize the group, by selling its Hong Kong operations. According to analysts, other international operations may be sold off as the company’s share price continues to struggle. “I’d like them to think about exiting Turkey, France, Italy, and Poland,” Abid Hussain, an insurance analyst at Credit Suisse, told Financial Times. Meanwhile, the industry may still see further activity from Prudential – with James predicting a potential separation between the firm’s business in Asia and Jackson National Life, its US subsidiary. “Prudential Asia should be a standalone company,” James told Financial Times. “I don’t think being tied to Jackson does it any favours — it very clearly damages the valuation. It would be to the benefit of shareholders to have Jackson out of the group, almost at any price.” spud | spud | |
30/12/2019 11:26 | Aside from MF though, there are plenty of Brokers.Newspapers and Tipsters all positive on Aviva's prospects. | imagining | |
30/12/2019 09:39 | MF has some appalling writers and meaningless articles. Take this one Basically just takes the first 10 ftse100 co’s and looks at their sp’s over 5 years, and ignores dividends as it probably makes the maths too hard. It just churns out large volumes of rubbish. No insight. Utter garbage. | ![]() dr biotech | |
30/12/2019 08:51 | Kiss of death. | ![]() lord gnome | |
30/12/2019 08:45 | Isn't that good news? | ![]() adelwire2 | |
29/12/2019 21:06 | Motley fool share tip for 2020. | ![]() adelwire2 | |
25/12/2019 12:14 | Merry Christmas to all | ![]() whatsup32 | |
23/12/2019 18:36 | well, something needs to be done to trigger a share price re-rating. Aviva shares have under-performed for far too long now - so either the existing management team have to be more proactive or somebody else will do it. | ![]() ukneonboy | |
23/12/2019 17:01 | Problem is CEO He was either second or third choice to take over the company . I recall Board spending over a year to find a replacement for the last CEO. If Tulloch was a compelling choice it would not have taken that long . I believe board extended the time to look for alternative to Tulloch and couldn’t tempt anyone . We as shareholders are paying the price. All he has done so far is taken most of Asian businesses of the market. I watched his first investor presentation my Lord I was bored to tears , | ![]() whatsup32 | |
23/12/2019 16:27 | im not so sure. first you would lose the diversity benefit between life and general which isnt insignificant. secondly, you would have a concentrated bet on uk longevity and house prices which didnt work out too well for JRP. thirdly you would have to break up or segregate aviva investors in some shape which would be messy and probably value destructing. ditching canada prob makes sense and im not sure france is a particular growth market but diversity adds value i think | ![]() cjac39 | |
23/12/2019 16:12 | I would think a stand-alone Life, Pensions & Annuity business would attract a higher rating than a General Insurance business dominated by House & Car insurance. I think the break-up argument would actually unlock shareholder value at Aviva - possibly like Prudential spinning-off M&G into a seperately quoted business. | ![]() ukneonboy | |
23/12/2019 14:14 | It's already divisional and costs can be shared. | ![]() jordaggy | |
23/12/2019 14:02 | but surely the value of the 2 separate bits will be worth more (ie valued more highly by the market) than the current enlarged group ?? A focused general insurance business and a separate focused life and annuity business would seem a great idea to me. Management then focuses on "their" individual ops. rather than a large cumbersome business | ![]() ukneonboy | |
23/12/2019 13:54 | A breakup will cost 10's of millions...leave be I say. | ![]() jordaggy | |
23/12/2019 13:07 | what am I missing here ? can't understand why AV. shares are down today if "activist shareholders" are pushing AV. management to focus operations, which might involve separating general insurance ops from life ops. surely this should be good news. | ![]() ukneonboy | |
23/12/2019 11:43 | Please, take it over someone | ![]() uppompeii | |
23/12/2019 11:12 | From Sunday: Board bust-up at Aviva over chief executive's decision not to split firm By DAILY MAIL CITY & FINANCE REPORTER PUBLISHED: 23:00, 22 December 2019 | UPDATED: 00:51, 23 December 2019 A boardroom bust-up has broken out at Aviva after its chief executive backtracked on a plan to split the insurer into two. A proposal drafted this year laid out plans to separate the company’s general insurance arm from its life insurance division. But despite boardroom support for the deal, chief executive Maurice Tulloch (pictured) opted instead for a watered-down restructuring that simplified the business by eliminating nine of its 14 divisions, leaving just five. The original deal was expected to add billions to the company’s stock market value, and its rejection is thought to have caused dismay on the board. Several bosses now fear the £16billion firm could be the target of an activist investor, The Sunday Telegraph reported. Other insurers, including Prudential and Legal & General, have split parts of their business. Aviva declined to comment last night. spud | spud | |
23/12/2019 09:07 | More in the times hxxps://www.thetimes Doesn’t add a lot, just a rehash of the telegraph article. Unfortunately some of the telegraph articles have been really ropey recently, it’s not a paper I trust anymore | ![]() dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions